Duan Chunhui, Hu Dandan, Tang Xinming, Suo Jingxia, Wang Si, Zhang Sixin, Tao Geru, Li Chao, Wang Chaoyue, Gu Xiaolong, Tang Xiaoli, Huang Guangping, Xiang Biqi, Wu Shaoqiang, Mamoun Choukri Ben, Suo Xun, Liu Xianyong
State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, 100193, China; National Animal Protozoa Laboratory, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
Chinese Academy of Inspection and Quarantine, Yizhuang, Beijing, China.
Mol Biochem Parasitol. 2019 Mar;228:1-5. doi: 10.1016/j.molbiopara.2019.01.002. Epub 2019 Jan 15.
Eimeria spp., the causative agents of coccidiosis, are the most common protozoan pathogens of chickens. Infection with these parasites can result in poor development or death of animals leading to a devastating economic impact on poultry production. The establishment of transfection protocols for genetic manipulation of Eimeria species and stable expression of genes would help advance the biology of these parasites as well as establish these organisms as novel vaccine delivery vehicles. Here, we report the selection of the first stable transgenic E. necatrix population, EnHA1, consitutively expressing the EYFP reporter following transfection of the 2 generation merozoites with a linear DNA fragment harboring the EYFP reporter gene, the HA1 gene from the avian influenza virus H9N2 and the TgDHFR-TS selectable marker, which confers resistance to pyrimethamine. Transfected merozoites were inoculated into chickens via the cloacal route, and feces from 18 h to 72 h post inoculation were collected and subjected to subsequent serial passages, FACS sorting and pyrimethamine selection. A gradual increase in the number of EYFP-expressing sporulated oocysts was noticed with more than 90% EYFP + oocysts obtained after five passages. Immunofluorescence assay confirmed successful expression of the HA1 antigen in the EnHA1 population. The ability to genetically manipulate E. necatrix merozoites and express heterologous genes in this parasite will pave the way for possible use of this organism as a vaccine-delivery vehicle.
艾美耳球虫属是球虫病的病原体,是鸡最常见的原生动物病原体。感染这些寄生虫会导致动物发育不良或死亡,给家禽生产带来毁灭性的经济影响。建立艾美耳球虫属的基因操作转染方案以及基因的稳定表达,将有助于推动这些寄生虫的生物学研究,并将这些生物体确立为新型疫苗载体。在此,我们报告了首个稳定的转基因柔嫩艾美耳球虫种群EnHA1的筛选情况,在用携带增强型黄色荧光蛋白(EYFP)报告基因、来自禽流感病毒H9N2的HA1基因以及赋予对乙胺嘧啶抗性的TgDHFR-TS选择标记的线性DNA片段转染第2代裂殖子后,该种群持续表达EYFP报告基因。将转染后的裂殖子通过泄殖腔途径接种到鸡体内,收集接种后18小时至72小时的粪便并进行后续的连续传代、荧光激活细胞分选(FACS)和乙胺嘧啶选择。发现表达EYFP的孢子化卵囊数量逐渐增加,经过5次传代后获得了超过90%的EYFP阳性卵囊。免疫荧光分析证实HA1抗原在EnHA1种群中成功表达。对柔嫩艾美耳球虫裂殖子进行基因操作并在这种寄生虫中表达异源基因的能力,将为将这种生物体用作疫苗载体的可能性铺平道路。